Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03612804 · ClinicalTrials.gov registry record · NA
Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 944
- Enrollment target
NCT03612804: Completed NA study, sponsored by VA Office of Research and Development.
NCT03612804 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 944 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03612804, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 944 participants
- Enrollment target
Study Summary
This pragmatic trial will evaluate the value of routinely providing proactive smoking cessation support to current smokers as a part of participating in lung cancer screening within Veterans Health Administration.
Interventions
- BEHAVIORAL Unsigned note to provider about cessation medication prescription
- BEHAVIORAL Proactive Telephone Counseling from VA Quitline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 944 participants |
| Start Date | 2019-05-10 |
| Est. Completion | 2023-02-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03612804
The ClinicalTrials.gov registry entry for NCT03612804 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 944 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Unsigned note to provider about cessation medication prescription is the first listed.
NCT03612804 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03612804 about?
NCT03612804 is a clinical study titled "Promoting Smoking Cessation in Lung Cancer Screening Through Proactive Treatment". This pragmatic trial will evaluate the value of routinely providing proactive smoking cessation support to current smokers as a part of participating in lung cancer screening within Veterans Health Administration.
What is the current status of trial NCT03612804?
This trial is currently completed. It is a NA study. The enrollment target is 944 participants. The study started on 2019-05-10. Estimated completion is 2023-02-09.
What interventions are being tested in trial NCT03612804?
The interventions under investigation include: Unsigned note to provider about cessation medication prescription (BEHAVIORAL), Proactive Telephone Counseling from VA Quitline (BEHAVIORAL).
Who is sponsoring clinical trial NCT03612804?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.